Cases & Deals

  • Home
  • Practices
  • XAnge leads €2.6 million financing round of Core Biogenesis

Share

XAnge leads €2.6 million financing round of Core Biogenesis

November 2020

Client(s) Siparex/XAnge

Jones Day advised XAnge in connection with the €2.6 million financing round of Core Biogenesis, a French company engaged in the development of processes using plants as biofactories to produce growth factors and other recombinant proteins.

Contacts

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.